These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1070 related articles for article (PubMed ID: 21091273)

  • 1. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
    Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
    J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer.
    Liu Y; Chen Z; Liu C; Yu D; Lu Z; Zhang N
    Biomaterials; 2011 Aug; 32(22):5167-76. PubMed ID: 21521627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
    Fu Y; Raatschen HJ; Nitecki DE; Wendland MF; Novikov V; Fournier LS; Cyran C; Rogut V; Shames DM; Brasch RC
    Biomacromolecules; 2007 May; 8(5):1519-29. PubMed ID: 17402781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.
    Cheng JJ; Zhu J; Liu XS; He DN; Xu JR; Wu LM; Zhou J; Feng Q
    Acta Radiol; 2012 Oct; 53(8):900-7. PubMed ID: 22919051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrothermally synthesized PEGylated calcium phosphate nanoparticles incorporating Gd-DTPA for contrast enhanced MRI diagnosis of solid tumors.
    Mi P; Kokuryo D; Cabral H; Kumagai M; Nomoto T; Aoki I; Terada Y; Kishimura A; Nishiyama N; Kataoka K
    J Control Release; 2014 Jan; 174():63-71. PubMed ID: 24211705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI.
    Faucher L; Tremblay M; Lagueux J; Gossuin Y; Fortin MA
    ACS Appl Mater Interfaces; 2012 Sep; 4(9):4506-15. PubMed ID: 22834680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
    Ahrén M; Selegård L; Klasson A; Söderlind F; Abrikossova N; Skoglund C; Bengtsson T; Engström M; Käll PO; Uvdal K
    Langmuir; 2010 Apr; 26(8):5753-62. PubMed ID: 20334417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gd-DTPA-loaded polymer-metal complex micelles with high relaxivity for MR cancer imaging.
    Mi P; Cabral H; Kokuryo D; Rafi M; Terada Y; Aoki I; Saga T; Takehiko I; Nishiyama N; Kataoka K
    Biomaterials; 2013 Jan; 34(2):492-500. PubMed ID: 23059004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles.
    Xu ZP; Kurniawan ND; Bartlett PF; Lu GQ
    Chemistry; 2007; 13(10):2824-30. PubMed ID: 17186555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gadolinium-loaded nanoparticle as a novel molecular imaging contrast agent for magnetic resonance imaging].
    Liu LZ; Guo GJ; Zeng MS; Lü YC; Liu XW; Cui CY; Wu PH; Li L
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):240-3. PubMed ID: 17425867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
    Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
    Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers.
    Rowe MD; Chang CC; Thamm DH; Kraft SL; Harmon JF; Vogt AP; Sumerlin BS; Boyes SG
    Langmuir; 2009 Aug; 25(16):9487-99. PubMed ID: 19422256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique.
    Park SJ; Kim SH
    J Colloid Interface Sci; 2004 Mar; 271(2):336-41. PubMed ID: 14972610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadolinium-labeled peptide dendrimers with controlled structures as potential magnetic resonance imaging contrast agents.
    Luo K; Liu G; She W; Wang Q; Wang G; He B; Ai H; Gong Q; Song B; Gu Z
    Biomaterials; 2011 Nov; 32(31):7951-60. PubMed ID: 21784511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
    Sant S; Poulin S; Hildgen P
    J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent.
    Han L; Li J; Huang S; Huang R; Liu S; Hu X; Yi P; Shan D; Wang X; Lei H; Jiang C
    Biomaterials; 2011 Apr; 32(11):2989-98. PubMed ID: 21277017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface modification of gadolinium oxide thin films and nanoparticles using poly(ethylene glycol)-phosphate.
    Guay-Bégin AA; Chevallier P; Faucher L; Turgeon S; Fortin MA
    Langmuir; 2012 Jan; 28(1):774-82. PubMed ID: 21970413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-based cascade polymer contrast agents: preclinical evaluations.
    Raatschen HJ; Fu Y; Shames DM; Wendland MF; Brasch RC
    Invest Radiol; 2006 Dec; 41(12):860-7. PubMed ID: 17099424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties evaluation of a new MRI contrast agent based on Gd-loaded nanoparticles.
    Riyahi-Alam N; Behrouzkia Z; Seifalian A; Haghgoo Jahromi S
    Biol Trace Elem Res; 2010 Dec; 137(3):324-34. PubMed ID: 20049554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.